Bioinformatics & AI for Comprehensive Multiomics

Unlocking insights with AI: Multiomics analysis for target enhancer discovery

In the world of life sciences, deciphering complex biological mechanisms requires a fusion of advanced computational techniques and deep biological expertise. Our recent collaboration leveraged AI-driven bioinformatics to analyze multiomics data, identifying key regulatory elements that influence gene expression.

The challenge: Decoding gene regulation at scale

Understanding gene regulation is crucial for advancing disease research and therapeutic development. However, integrating multiple layers of omics data—such as ATAC-seq, ChIP-seq, RNA-seq, DNAse-seq, and CAGE data—to pinpoint meaningful biological signals presents a significant challenge.

Approach: AI meets bioinformatics

By combining bioinformatics analysis with deep learning models, we developed a robust workflow that:

  • Aggregated multiomics data to detect key enhancers regulating gene expression.
  • Applied the Enformer deep learning model, which predicts regulatory elements in a long-range sequence context.
  • Identified transcription factor modulators, crucial for cell type reprogramming.
  • Validated candidate targets and enhancers, feeding them into experimental pipelines for further study.

Results: AI in biological discovery

  • Robust detection – Successfully identified sequence elements and proteins modulating a target gene.
  • AI + bioinformatics synergy – Independent computational approaches converged on a shortlist of high-confidence candidates.
  • Biological interpretation – Functional analysis and expert consultation provided a deeper understanding of the biological processes involved.

Conclusion

This AI-powered approach enables researchers to accelerate discoveries in gene regulation, helping identify potential therapeutic targets with greater accuracy. By integrating deep learning and bioinformatics, we can uncover hidden patterns in genomic data, bringing us closer to groundbreaking advancements in precision medicine.

Interested in how AI-driven multiomics analysis can support your research? Get in touch with us today!

Expert Contribution

Reviewed by: Dr. Marek Kudła, PhD
Role: Senior Scientist, AI-Driven Drug Discovery
Expertise: Small molecule drug design, computational chemistry, machine learning modeling

You might be also interested in:

Webinar: Lab-in-the-Loop: reclaiming the 50% of scientific time lost to data
Lab-in-the-Loop: reclaiming the 50% of scientific time lost to data
Blog cover for Ardigen publication on ARDisplay-I and MHC ligand identification in Molecular & Cellular Proteomics
New publication in MCP: Improving MHC ligand identification with machine learning and optimized isolation
Fluorescence microscopy image of cells stained with multiple Cell Painting dyes showing cellular organelles in green, blue, and pink, overlaid with Ardigen brand graphic elements indicating phenomics data in durg discovery
End to End Data-to-Decision Journey for AI-Driven Phenomics in Drug Discovery
Abstract network visualization representing AI-driven integration of biological data and knowledge graphs for target identification in drug discovery.
Target Identification: From Poor Data to Quality Predictions

Contact

Ready to transform drug discovery?

Discover how one of the top AI CROs in the world, can be your trusted partner in revolutionizing drug discovery through AI.

Contact us today to learn more about our tailored solutions for empowering your drug development journey.

Send us a message and we will contact you back within 48 hours.

Newsletter

Become an insider

Be the first to know about Ardigen’s latest news and get access to our publications, webinars and more!